auto_awesome
Want to know who else bid on this?
Proposal Forge correlates this contract with the original RFP, the losing bidders, and the next recompete window.
Purpose
LFAnt is developing two distinct proof-of-concept instrument-less colorimetric liquid assays for the rapid saliva-based detection of (1) the SARS-CoV-2 virus and (2) its associated antibodies. LFANT's colorimetric liquid assay technology is
LFAnt Medical × Unknown
1 grants totalling $100.0K
Collaborative Science, Technology and Innovation Program - Collaborative R&D Initiatives
1,000 grants totalling $348.9M
Related Grants
| Recipient | Amount | Program |
|---|---|---|
| Quantum Valley Ideas Laboratories | $1.2M | Collaborative Science, Technology and In... |
| Centre for Commercialization of Cancer Immunotherapy | $1.0M | Collaborative Science, Technology and In... |
| Centre for Commercialization of Cancer Immunotherapy | $1.0M | Collaborative Science, Technology and In... |
| Mitacs inc. | $1.0M | Collaborative Science, Technology and In... |
| Mitacs inc. | $1.0M | Collaborative Science, Technology and In... |